Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byeong Hoon Kang

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|July 9, 2022
Dendritic Cell-Based Immunotherapy in Hot and Cold TumorsByeong Hoon Kang, Heung Kyu Lee
Immune Network|November 12, 2025
Unlocking IL-33: New Insights into Tumor ImmunityByeong Hoon Kang, Heung Kyu Lee
Frontiers in Immunology|June 27, 2022
A Microbiota-Dependent Subset of Skin Macrophages Protects Against Cutaneous Bacterial InfectionYoung Joon Park, Byeong Hoon Kang, Hyun-Jin Kim, et al.
Frontiers in Immunology|June 12, 2023
Harnessing type I interferon-mediated immunity to target malignant brain tumorsJuhee Lim, In Kang, Jeongwoo La, et al.
Antiviral Research|June 16, 2023
Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2Hi Eun Jung, Keun Bon Ku, Byeong Hoon Kang, et al.
Cell Reports|June 27, 2025
Gut microbiota dysbiosis induced by brain tumors modulates the efficacy of immunotherapyHyeon Cheol Kim, Hyun-Jin Kim, Jeongwoo La, et al.
Iscience|September 17, 2024
Type I interferon signaling regulates myeloid and T cell crosstalk in the glioblastoma tumor microenvironmentJuhee Lim, Jeongwoo La, Hyeon Cheol Kim, et al.
Biosensors & Bioelectronics|November 16, 2025
Nanoplasmonic real-time RT-RPA and CRISPR/Cas12a detection for rapid point-of-care molecular diagnosticsEun-Sil Yu, Hyowon Jang, Jae-Myeong Kwon, et al.
Journal for Immunotherapy of Cancer|October 26, 2024
Inhibitory Fcγ receptor deletion enhances CD8 T cell stemness increasing anti-PD-1 therapy responsiveness against glioblastomaKeun Bon Ku, Chae Won Kim, Yumin Kim, et al.
Cell Reports|October 7, 2023
Supplementation with a high-glucose drink stimulates anti-tumor immune responses to glioblastoma via gut microbiota modulationJaeho Kim, Yumin Kim, Jeongwoo La, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|July 9, 2022
Dendritic Cell-Based Immunotherapy in Hot and Cold TumorsByeong Hoon Kang, Heung Kyu Lee
Immune Network|November 12, 2025
Unlocking IL-33: New Insights into Tumor ImmunityByeong Hoon Kang, Heung Kyu Lee
Frontiers in Immunology|June 27, 2022
A Microbiota-Dependent Subset of Skin Macrophages Protects Against Cutaneous Bacterial InfectionYoung Joon Park, Byeong Hoon Kang, Hyun-Jin Kim, et al.
Frontiers in Immunology|June 12, 2023
Harnessing type I interferon-mediated immunity to target malignant brain tumorsJuhee Lim, In Kang, Jeongwoo La, et al.
Antiviral Research|June 16, 2023
Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2Hi Eun Jung, Keun Bon Ku, Byeong Hoon Kang, et al.
Cell Reports|June 27, 2025
Gut microbiota dysbiosis induced by brain tumors modulates the efficacy of immunotherapyHyeon Cheol Kim, Hyun-Jin Kim, Jeongwoo La, et al.
Iscience|September 17, 2024
Type I interferon signaling regulates myeloid and T cell crosstalk in the glioblastoma tumor microenvironmentJuhee Lim, Jeongwoo La, Hyeon Cheol Kim, et al.
Biosensors & Bioelectronics|November 16, 2025
Nanoplasmonic real-time RT-RPA and CRISPR/Cas12a detection for rapid point-of-care molecular diagnosticsEun-Sil Yu, Hyowon Jang, Jae-Myeong Kwon, et al.
Journal for Immunotherapy of Cancer|October 26, 2024
Inhibitory Fcγ receptor deletion enhances CD8 T cell stemness increasing anti-PD-1 therapy responsiveness against glioblastomaKeun Bon Ku, Chae Won Kim, Yumin Kim, et al.
Cell Reports|October 7, 2023
Supplementation with a high-glucose drink stimulates anti-tumor immune responses to glioblastoma via gut microbiota modulationJaeho Kim, Yumin Kim, Jeongwoo La, et al.
Pageof 2